TENEO 317 Model 2 excimer laser: Clinical Trials

2 trials of TENEO 317 Model 2 excimer laser, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1

Follow TENEO 317 Model 2 excimer laser: new trials by email Literature Review of TENEO 317 Model 2 excimer laser trials Research Report on TENEO 317 Model 2 excimer laser

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy
TENEO 317 Model 2 excimer laser - Myopia
Not applicableNot yet recruitingBausch & Lomb Incorporated1402025-11-012025-06-15
Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism
TENEO 317 Model 2 excimer laser - Hyperopia
Not applicableCompletedBausch & Lomb Incorporated1402022-11-152026-10-08

Conditions studied

Hyperopia (1)  ·  Myopia (1)

Sponsors

Bausch & Lomb Incorporated (2)

Countries

United States (1)

Top investigators

Rosangela Nolasco (1)